Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T07:33:09.146Z Has data issue: false hasContentIssue false
  • English
  • Français

Designing a Multicenter Registry of COVID-19 and Other Respiratory Infections in Fars, Iran

Published online by Cambridge University Press:  06 April 2021

Amir Emami ,
Ali Akbari ,
Fatemeh Javanmardi ,
Mehrzad Lotfi ,
Mohsen Moghadami ,
Mehrdad Sharifi ,
Hamid Bakhtiari  and
Farshad Falahati
Amir Emami*
Affiliation:
Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Ali Akbari
Affiliation:
Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Fatemeh Javanmardi
Affiliation:
Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Mehrzad Lotfi
Affiliation:
Department of Radiology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Mohsen Moghadami
Affiliation:
Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
Mehrdad Sharifi
Affiliation:
Emergency Medicine Department, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Hamid Bakhtiari
Affiliation:
Vice Chancellor for Health Affairs Center of Disease Control (CDC), Shiraz University of Medical Sciences, Shiraz, Iran
Farshad Falahati
Affiliation:
Vice Chancellor for Treatment, Shiraz University of Medical Sciences, Shiraz, Iran
*
Corresponding author: Amir Emami, Email: Emami.microbia@gmail.com.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

A year after the emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a new crisis in respiratory infections, there remain many uncertainties and unknowns about SARS-CoV-2 and the disease it causes, called coronavirus disease (COVID-19). Although COVID-19 is known as a respiratory disease, some atypical manifestations have been seen, different from those seen in other types of viral respiratory infections. This paper aims to describe designing, launching, and implementing a data collection system for all respiratory diseases, with a focus on SARS-CoV-2 from the onset of this pandemic.

Method:

The current registry is designed in compliance with the standard Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, along with the declaration of Helsinki principles.

Results:

A respiratory disease registry, with an emphasis on COVID-19 and other co-infections, was developed. Data consisted of demographic, clinical, and supporting information about SARS-CoV-2 and other respiratory viral diseases.

Conclusion:

It is hoped that the current data registry will facilitate patient evaluation and improve the outcomes of cases of respiratory infection defined by a particular condition, disease, or exposure. Moreover, the registry can harmonize data about the treatment, outcomes, and well-being of patients who receive care over time, and identify best practices.

Keywords

COVID-19FarsIranregistrysevere acute respiratory syndrome coronavirus 2
Type
Commentary
Information
Disaster Medicine and Public Health Preparedness , Volume 16 , Issue 5 , October 2022 , pp. 1761 - 1764
Copyright
© Society for Disaster Medicine and Public Health, Inc. 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wiersinga, WJ, Rhodes, A, Cheng, AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782-793.CrossRefGoogle ScholarPubMed
Sohrabi, C, Alsafi, Z, O’Neill, N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-76.CrossRefGoogle Scholar
Moriyama, M, Hugentobler, WJ, Iwasaki, A. Seasonality of respiratory viral infections. Annu Rev Virol. 2020;7(1):83-101.CrossRefGoogle ScholarPubMed
Cheng, MP, Papenburg, J, Desjardins, M, et al. Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review. Ann Intern Med. 2020;172(11):726-734.CrossRefGoogle ScholarPubMed
Keshavarzi, A, Mohammadi, AA, Ayaz, M, et al. Cutaneous vesicular of COVID-19 in two burn patients. World J Plast Surg. 2020;9(3):331-338.Google ScholarPubMed
Emami, A, Javanmardi, F, Keshavarzi, A, Pirbonyeh, N. Hidden threat lurking behind the alcohol sanitizers in COVID-19 outbreak. Dermatol Ther. 2020;33(4):e13627.CrossRefGoogle ScholarPubMed
Lawrenson, JG, Buckley, RJ. COVID-19 and the eye. Ophthalmic Physiol Opt. 2020;40(4):383-388.CrossRefGoogle ScholarPubMed
Konala, VM, Adapa, S, Gayam, V, et al. Co-infection with Influenza A and COVID-19. Eur J Case Rep Intern Med. 2020;7(5):001656.Google ScholarPubMed
Yuen, K-S, Ye, ZW, Fung, SY, et al. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10(1):1-5.CrossRefGoogle ScholarPubMed
von Elm, E, Altman, DG, Egger, M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-577.CrossRefGoogle ScholarPubMed
Harriss, D, Atkinson, G. Ethical standards in sport and exercise science research: 2016 update. Int J Sports Med. 2015;36(14):1121-1124.Google ScholarPubMed
Khorrami, F, Shahi, M, DavariDolatabadi, N, et al. Implementation of regional COVID-19 registry in Hormozgan (RCovidRH), Iran: rationale and study protocol. Med J Islam Repub Iran. 2020;34(1):676-683.Google ScholarPubMed
Dandachi, D, Geiger, G, Montgomery, MW, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with HIV and coronavirus disease-19. Clin Infect Dis. 2020;epub:ciaa1339. doi: 10.1093/cid/ciaa1339.CrossRefGoogle Scholar
Ciminelli, G, Garcia-Mandicó, S. COVID-19 in Italy: an analysis of death registry data. J Public Health. 2020;epub:fdaa165. doi: 10.1093/pubmed/fdaa165.Google Scholar
Emami, A, Javanmardi, F, Akbari, A, et al. Survival rate in hypertensive patients with COVID-19. Clin Exp Hypertens. 2021;43(1):77-80.CrossRefGoogle ScholarPubMed
Emami, A, Javanmardi, F, Akbari, A, et al. Characteristics of deceased patients with COVID-19 after the first peak of the epidemic in Fars Province, Iran. Infect Ecol Epidemiol. 2020;10(1):1781330.Google ScholarPubMed
Emami, A, Fadakar, N, Akbari, A, et al. Seizure in patients with COVID-19. Neurol Sci. 2020;41(11):3057-3061.CrossRefGoogle ScholarPubMed